MSA
REGN icon

MUFG Securities Americas’s Regeneron Pharmaceuticals REGN Stock Holding History

MUFG Securities Americas’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.15M Buy
2,789
+74
+3% +$56.7K 0.14% 136
2025
Q4 		$2.1M Sell
2,715
-33
-1% -$22.4K 0.13% 137
2025
Q3 		$1.55M Buy
2,748
+447
+19% +$253K 0.1% 181
2025
Q2 		$1.21M Buy
2,301
+439
+24% +$245K 0.1% 179
2025
Q1 		$1.18M Buy
1,862
+308
+20% +$212K 0.14% 143
2024
Q4 		$1.11M Buy
+1,554
New +$1.3M 0.14% 134

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MUFG Securities Americas's REGN Position: Q1 2026 in Review

MUFG Securities Americas increased its Regeneron Pharmaceuticals (REGN) stake by 2.7% in Q1 2026, buying an estimated $56.7K and bringing the position to 2,789 shares worth $2.15M. The position accounts for 0.14% of the portfolio, ranked #136.

MUFG Securities Americas first reported a position in REGN in Q4 2024 and has held it in 6 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • MUFG Securities Americas held 2,789 shares of Regeneron Pharmaceuticals worth $2.15M as of Q1 2026.
  • MUFG Securities Americas bought 74 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $56.7K.
  • Regeneron Pharmaceuticals made up 0.14% of MUFG Securities Americas's portfolio in Q1 2026, its #136 holding.
  • MUFG Securities Americas first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.